We evaluated the in vitro antimicrobial activity of Sch 24893, Sch 25298, and Sch 25393, three novel analogs of chloramphenicol and thiamphenicol. All of the analogs had minimal inhibitory concentrations of cl10 ig/ml for 18 chloramphenicol-thiamphenicol-resistant strains of Shigella dysenteriae and 21 strains of resistant Salmonella typhi. The analogs were also more active than were chloramphenicol and thiamphenicol against chloramphenicol-resistant enteric bacteria, including six strains of Escherichia coli, seven strains of Klebsiella pneumoniae, and two strains of Enterobacter cloacae. Fifty-three strains of ampicillinresistant Haemophilus influenzae were uniformly susceptible to chloramphenicol, thiamphenicol, and the three analogs. Sch 25298 was the most active compound tested (minimal inhibitory concentration, 0.5 /ig/ml for all strains). Four of seven chloramphenicol-thiamphenicol-resistant Haemophilus strains were susceptible to the fluorinated analogs. Of the three Haemophilus strains which were resistant to chloramphenicol, thiamphenicol, and the analogs, two contained less than 10% of the chloramphenicol acetyltransferase activity of the strains which were resistant to only chloramphenicol and thiamphenicol. We conclude that fluorinated analogs of chloramphenicol and thiamphenicol have considerable in vitro activity against a broad spectrum of chloraniphenicol-thiamphenicol-resistant, gram-negative bacteria.
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We evaluated the in vitro antimicrobial activity of three novel analogs of chloramphenicol and thiamphenicol. All ofthese compounds have a unique substitution at the 3' carbon positions; the hydroxyl group present in chloramphenicol and thiamphenicol is replaced by fluorine. Since chloramphenicol and thiamphenicol resistance is usually due to plasmid-mediated production of an acetyltransferase which acetylates the 3'-hydroxyl group (10) , it was hypothesized that enzymatic inactivation could not occur with such analogs. These drugs, therefore, should be active against the majority of plasmid-mediated, chloramphenicol-resistant isolates. The three analogs examined were Sch 24893 (the 3-fluoro derivative of chloramphenicol), Sch 25298 (the 3-fluoro derivative of thiamphenicol), and Sch 25393 (the 3-fluoro derivative of thiamphenicol in which the dichloroacetyl group is replaced by a difluoroacetyl group at the R' position) (Fig. 1) . Sixteen other strains of Enterobacteriaceae which were highly resistant to both thiamphenicol and chloramphenicol were also tested. Seven of the strains were resistant to 50 jig or more of Sch 24893 per ml, three were similarly resistant to Sch 25298, and two were resistant to Sch 25393. The species of Enterobacteriaceae tested are included in Table 1 .
We also examined the activity of the three analogs against selected antibiotic-resistant strains of H. influenzae. Fifty-three ampicillinresistant, chloramphenicol-and thiamphenicolsusceptible strains of IH. influenzae type b were susceptible to the three analogs (Table 2) . Sch 25298 was the most active; all strains were inhibited by 0.5,ug/ml. Sch 25393 was the least active; 5 jig/ml was required to inhibit 9 of the 53 strains. Five clinical isolates of H. influenzae which were resistant to chloramphenicol, with MICs of >50 jug/ml, were also studied ( Table 3 ).
All of these strains were type b except for strain D, which was nontypable. Four of the strains were susceptible to all three analogs, with MICs of 0.1 to 1.0 jig/ml. The three analogs had variable activity against the other three strains, with MICs ranging from 5 to 50 ,ug/ml. In addition, we studied an H. influenzae type b strain (strain (6) . ChmIa O-mefthlation or "naymatic 0.
acetylatlon resulte in cmonswithiout biological activity (5, 6) . The eseta aueOf the 3'..ydroxyl group was reinforced by the finding that R-pasmnd-mdaedmcoba e Isac to chloamphnlco was often through the production of 3X-chloraznphenicol awl WS, 9(7), corresponding difluoro isomer, were more active than the fluorinated derivative of chloramphenicol. Five isolates of H. influenzae resistant to chloramphenicol were studied for their susceptibility to the fluorinated analogs. Two were resistant. To gain insight into the mechanism of resistance to analogs lacking the 3'-hydroxyl group, we assayed the chloramphenicol acetyltransferase activity in cell extracts. Those isolates resistant to chloramphenicol, thiamphenicol, and the fluorinated analogs contained less than 10% of the chloramphenicol acetyltransferase activity of the strains which were resistant to chloramphenicol and thiamphenicol alone. The mechanism of resistance in the strains lacking chloramphenicol acetyltransferase may involve cell permeability or a mutation in ribosome-binding proteins (7) .
